Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis
Patent
1996-09-12
1999-01-05
Isabella, David J.
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
A61F 262
Patent
active
058556176
ABSTRACT:
Tissue which is suitable for transplant is treated with a growth factor and cells which populate the tissue and native cells must be removed, they cannot be "masked" reduce immunogenicity; this increases the longevity of the tissue upon transplant. The preferred growth factor is basic fibroblast growth factor, and the preferred cells are fibroblasts. The tissue can be an allograft or xenograft taken from a cow, pig or other mammal.
REFERENCES:
patent: 3966401 (1976-06-01), Hancock et al.
patent: 4240794 (1980-12-01), Holman et al.
patent: 4323358 (1982-04-01), Lentz et al.
patent: 4378224 (1983-03-01), Nimni et al.
patent: 4383832 (1983-05-01), Fraefel et al.
patent: 4402697 (1983-09-01), Pollock et al.
patent: 4405327 (1983-09-01), Pollock
patent: 4407787 (1983-10-01), Stemberger
patent: 4485096 (1984-11-01), Bell
patent: 4539716 (1985-09-01), Bell
patent: 4546500 (1985-10-01), Bell
patent: 4553974 (1985-11-01), Dewanjee
patent: 4559298 (1985-12-01), Fahy
patent: 4567847 (1986-02-01), Linner
patent: 4609551 (1986-09-01), Caplan
patent: 4642120 (1987-02-01), Nevo et al.
patent: 4647283 (1987-03-01), Carpentier et al.
patent: 4648881 (1987-03-01), Carpentier et al.
patent: 4688387 (1987-08-01), Conaway
patent: 4707998 (1987-11-01), Linner et al.
patent: 4776853 (1988-10-01), Klement et al.
patent: 4785079 (1988-11-01), Gospodarowicz
patent: 4798611 (1989-01-01), Freeman, Jr.
patent: 4799361 (1989-01-01), Linner
patent: 4801299 (1989-01-01), Brendel et al.
patent: 4828563 (1989-05-01), Muller-Lierheim
patent: 4835102 (1989-05-01), Bell et al.
patent: 4838888 (1989-06-01), Nashef
patent: 4870160 (1989-09-01), Charonis et al.
patent: 4878913 (1989-11-01), Aebischer et al.
patent: 4890457 (1990-01-01), McNally et al.
patent: 4902782 (1990-02-01), Gospodarowicz
patent: 4911710 (1990-03-01), Milthorpe et al.
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4960424 (1990-10-01), Grooters
patent: 4964280 (1990-10-01), Piunno et al.
patent: 4973493 (1990-11-01), Guire
patent: 5000963 (1991-03-01), Hefton
patent: 5002566 (1991-03-01), Carpentier et al.
patent: 5032508 (1991-07-01), Naughton et al.
patent: 5131850 (1992-07-01), Brockbank
patent: 5145770 (1992-09-01), Tubo et al.
patent: 5192312 (1993-03-01), Orton
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5215541 (1993-06-01), Nashef et al.
patent: 5219576 (1993-06-01), Chu et al.
patent: 5336616 (1994-08-01), Livesey et al.
patent: 5474770 (1995-12-01), Broly et al.
"Porcine Heterograft Valve Replacement in Children", by D.B. Williams, MD, G.K. Danielson, MD, D.C. McGoon, MD, F.J. Puga, MD, D.D. Mair, MD and W.D. Edwards MD, J. Thorac Cardiovasc Surg 84: pp. 446-450, Sep. 1982.
"Mechanical Testing of Cryopreserved Aortic Allografts Comparison with Xenografts and Fresh Tissue", by I. Vesely, PhD, L.Gonzalez-Lavin, MD, D. Graf and D. Goughner, MD, PhD, FRCPC, Journal of Thoracic and Cardiovascular Surgery, St. Louis , vol. 99, No. 1, pp. 119-123, Jan. 1990.
"An Approach to the Optimization of Preparation of Bioprosthetic Heart Valves", by D. Mavrilas and Yannis Missirlis, J. Biomechanics, vol. 24, No. 5 pp. 331-339, 1991.
Residual Heteroantigencity of Glutaraldehyde-Treated Porcine Cardiac Valves, by M.L. Villa, S. DeBiasi and F. Pilotto, Tissue Antigens, vol. 16, pp. 62-29, 1980.
"Tissue-Derived Biomaterials and Their Use In Cardiovascular Prosthetic Devices", by S.L. Hilbert, V.J. Ferrans, and M. Jones, Medical Progress Through Technology , vol. 14, pp. 115-153, 1988.
"Characterization of Pepsin-Solubilized Bovine Heart-Valve Collagen", by R.I. Bashey, H.M. Bashey and S.A. Jimenez, Biochem Journal, vol. 173, pp. 885-894, 1978.
"Collagen Heterogeneity in Pig Heart Valves", by P. Mannschott, D. Herbage, M. Weiss and C. Buffevant, Biochimica et Biophysica Acts , vol. 434, pp. 177-183, 1976.
"Preservation of Aortic Heart Valves with Maintenance of Cell Viability", by A.W. M. Van Der Kamp, MD, W.J. Visser, J.M. Van dongen, Ph.D., J. Nauta, MD and H. Galjaard, MD, Journal of Surgical Research , vol. 30, pp. 47-56, 1981.
"Viability of Connective Tissue Cells Following Storage of Aortic Valve Leaflets", by D.D. Reichenbach, MD, H. Mohri, MD, M. Sands and K.A., Merendino, MD, Journal of Thoracic and Cardiovascular Surgery, vol. 62, No. 5, pp. 690-695, Nov. 1971.
"Aortic Valve Replacement with Frozen Irradiated Homografts", by P.M. Beach, Jr., MD, F.O. Bowman, Jr., MD, G.A. Kaiser, MD, E. Parodi, MD and J.R. Malm, MD, Department of Surgery, College of Physcians and Surgeons, Columbia University, Supplement I to Circulation, vols.XLV and XLVI, pp. I-29--I 35, May 1972.
"Histological Assessment of Orthotopic Aortic Valve Leaflet Allografts: Its Role in Selecting Graft Pre-Treatment" by L.C. Armiger, J.B. Gavin and B.G. Barratt-Boyes, Pathology, vol. 15, pp. 67-73, 1983.
"A Comparison of Aortic Valve Replacement with Viable Cryopreserved and Fresh Allograft Valves, With a Note on Chromosomal Studies", by M.F. O'Brien, FRACS, FRCS, E. G. Stafford,FRACS, FACS, M.A.H. Gardner, FRACS, P.G. Pohlner, FRACS, D.C. McGiffin, FRACS, J.W. Kirklin, MD, Journal of Thoracic and Cardiovasular Surgery, vol. 94, No. 6, pp. 812-823, Dec. 1987.
"Cryopreserved Viable Allograft Aortic Valves", by M.F. O'Brien, E.G. Stafford, M.A.H. Gardner, P. Pohlner, D.C. McGrinnin, M. Johnston, P. Tesar, A. Brosnan, P. Duffy, (Prince Charles Hospital), Brisbane, Australia, pp. 311-321.
"The Viable Cryopreserved Allograft Aortic Valve", by M.F. O'Brien, FRACS, G. Stafford, FRACS, M. Gardner, FRACS, P. Pohlner, FRACS, D. McGiffin, FRACS, N. Johnston, FRACPA, A. Brosnan, B.Sc, and P. Duffy, MBBS, PhD, J. Cardiac Surg, vol. 1, No. 3, Supplement, pp. 153-167, 1987.
"Durability of The Viable Aortic Allograft", by W.W. Angell, MD, J.H. Oury, MD, J.J. Lamberti, MD and J. Koziol, PhD, J. Cardiovaic Surg, vol. 98, pp. 48-56, 1989.
"Xenotransplantation: A View to the Future", by F.H. Bach, Transplantation Proceedings, vol. 25, No. 1, pp. 25-29, Feb. 1993.
"New Biologic and Synthetic Vascular Prostheses", by H.P. Greisler, MD, Medical Intelligence Unit, Chapter 3, Biohybrids-Biological Coatings In Synthetic Grafts, pp. 33-46.
"Immunological Aspects of Treated Natural Tissue Prostheses", by P.K. Bajpai, Chapter 2, vol. 1, pp. 5-25.
"Improved Endothelial Viability of Heart Valves Cryopreserved by a New Technique", by E.J. Feng, C.E. van Hove, R. Mohan, L. Andries, M. Rampart, A.G. Herman and P.J. Walter, Eur J. Cardio-Thoracic Surgeryvol. 6, pp. 251-155, 1992.
"Xenografts--Future Prospects for Clinical Transplantation", by T.D.H. Cairns, D.H. Taube, N. Stevens, R. Binns and K.I. Welsh, Immunology Letters, vol. 29, pp. 167-170, 1991.
"Transplantation Immunology", by C.H. Kirkpatrick, MD, D.T. Rowlands, Jr., MD, JAMA, vol. 268, No. 20, pp. 2952-2958, Nov. 25, 1992.
"Cryopreservation Does Not Alter Antigenic Expression of Aortic Allografts", by R.P. Cochran, MD and K.S. Kunzelman, BS,Journal of Surgical Research, vol. 46, pp. 597-599, 1989.
"Effect of Cryopreservation on the Presence of Endothelial Cells on Human Valve Allografts", by F.M. Lupinetti, MD, T.T. Tsai, J.M. Kneebone, MS and E.L. Bove, MD, J. Thorac Cardio-Vasc Surg, vol. 106, pp 912-917, 1993.
"Effects of Cell Removal Upon Heart Valve Leaflet Mechanics and Immune Responses in a Xenogeneic Model", by S. Goldstein & K. Brockbank, Poster Abstracts, P29.
"Lack of Cross-Species Sensitization Between Skin Allo-and Xenotransplants in Mice", by C. Vizler, T. Janossy, Z. Tabi, P. Vegh, Institute of Experimental Surgery, Poster Abstracts, P30.
"Failure of Cryopreserved Homograft Valved Conduits in the Pulmonary Circulation", by D.C. Cleveland, MD, W.G. Williams, MD, A.J. Razzouk, MD, G.A. Trusler, MD, I.M. Rebeyka, MD, L. Duffy, PhD, Z. Kan, MD, J.G. Coles, MD and R.M. Freedom, MD, (circulation from the Divisions of Cardiovascular Surgery and Cardiology, The Hospital for Sick Children, II pp. 150-153).
"Degeneration of Aortic Valve Allografts in Young Recipients", by D. R. Clarke, MD, D.N. Campbell, MD, A.R. Hayward, MD, PhD and D.A. Bishop, BS, J Thorac Cardiovasc Surg, vol. 105, pp. 934-942, 1993.
"Immunogenicity of Tanned Tissue V
Colorado State University Research Foundation
Isabella David J.
LandOfFree
Treated tissue for implantation and methods of treatment and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treated tissue for implantation and methods of treatment and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treated tissue for implantation and methods of treatment and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-857969